Analytical Data
-
Gene name
ALPP
- Application
-
Alternative Names
ALPP；PLAP；Alkaline phosphatase. placental type
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P05187
-
Expression Region
23-506aa
-
AA Sequence
IIPVEEENPDFWNREAAEALGAAKKLQPAQTAAKNLIIFLGDGMGVSTVTAARILKGQKKDKLGPEIPLAMDRFPYVALSKTYNVDKHVPDSGATATAYLCGVKGNFQTIGLSAAARFNQCNTTRGNEVISVMNRAKKAGKSVGVVTTTRVQHASPAGTYAHTVNRNWYSDADVPASARQEGCQDIATQLISNMDIDVILGGGRKYMFRMGTPDPEYPDDYSQGGTRLDGKNLVQEWLAKRQGARYVWNRTELMQASLDPSVTHLMGLFEPGDMKYEIHRDSTLDPSLMEMTEAALRLLSRNPRGFFLFVEGGRIDHGHHESRAYRALTETIMFDDAIERAGQLTSEEDTLSLVTADHSHVFSFGGYPLRGSSIFGLAPGKARDRKAYTVLLYGNGPGYVLKDGARPDVTESESGSPEYRQQSAVPLDEETHAGEDVAVFARGPQAHLVHGVQEQTFIAHVMAFAACLEPYTACDLAPPAGTTD
-
Molecular Weight
54.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of ALPP (alkaline phosphatase placental-like protein) recombinant proteins has gained significant attention due to their potential applications in various fields, including biomedicine and biotechnology. ALPP, classified as a type of alkaline phosphatase, is predominantly expressed in the placenta and has been implicated in several physiological processes, such as mineralization and cellular signaling. The recombinant expression of ALPP allows researchers to produce large quantities of the protein for detailed biochemical studies, enabling a better understanding of its functional roles in health and disease. Moreover, ALPP exhibits unique properties that make it an attractive candidate for diagnostic and therapeutic applications, including its involvement in tumor growth and metastasis. As a result, recombinant ALPP proteins can be utilized as biomarkers for certain cancers or as targets in the development of novel treatment strategies. The production and characterization of these proteins through recombinant DNA technology have opened new avenues for research, allowing scientists to explore the mechanisms of action of ALPP in various biological contexts. Furthermore, this research holds promise in advancing our knowledge of related pathologies and developing innovative therapeutic approaches. Overall, the exploration of ALPP recombinant proteins represents a significant advancement in the fields of molecular biology and medical research, with the potential to contribute to improved diagnostic and therapeutic outcomes.
